All In Biotech

Drug Trial Radar · NCT07771465

A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

An Open-label Extension Study to Assess the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

332

Planned (sponsor's estimate)

Start

Aug 26, 2026

Primary completion

Nov 2032

Study completion Jan 2033

Sponsor

Lead sponsor
Kardigan, Inc.Industry
Sponsor type
Industry
First posted
Aug 18, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Danicamtiv is an investigational medication, which means it is still being studied and has not been approved. The purpose of this study is to learn how well danicamtiv works, how safe it is, how well people can take it when used in patients with genetic or familial dilated cardiomyopathy (DCM). There are currently no approved medicines made specifically to treat genetic or familial DCM.

Conditions

  • Symptomatic Genetic Dilated Cardiomyopathy (DCM)

Interventions

  • DanicamtivDrug

    Danicamtiv will be administered twice daily for up to 5 years

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Frequency and severity of treatment-emergent adverse events (TEAEs)Time frame: 61 months
  2. Frequency and severity of adverse events of special interest (AESIs)Time frame: 61 months
  3. Frequency and severity of serious adverse events (SAEs)Time frame: 61 months
  4. Frequency and severity of disease-related events (DREs)Time frame: 61 months
  5. Frequency of abnormal findings from physical examinationTime frame: 61 months
  6. Frequency of abnormal findings from vital signsTime frame: 61 months
  7. Frequency of abnormal findings from 12-lead electrocardiograms (ECGs)Time frame: 61 months
  8. Frequency of abnormal findings from clinical laboratory assessmentsTime frame: 61 months

Locations

78 sites in 11 countries. Site status is shown where the registry gives one.

  • University of Alabama Birmingham

    Birmingham, Alabama · Recruiting

  • Cedars Sinai

    Los Angeles, California · Recruiting

  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine

    Los Angeles, California · Not yet recruiting

  • University of California, San Diego (UCSD) - Medical Center

    San Diego, California · Not yet recruiting

  • University of California, San Francisco (UCSF)

    San Francisco, California · Not yet recruiting

  • Stanford University Medical Center

    Stanford, California · Not yet recruiting

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia · Recruiting

  • Mayo Clinic - Jacksonville

    Jacksonville, Florida · Not yet recruiting

  • Northwestern University

    Chicago, Illinois · Not yet recruiting

  • Louisiana State University (LSU) Health Sciences Center

    New Orleans, Louisiana · Not yet recruiting

  • Johns Hopkins Medicine

    Baltimore, Maryland · Not yet recruiting

  • Brigham and Women's Hospital

    Boston, Massachusetts · Recruiting

  • Henry Ford Health System

    Detroit, Michigan · Not yet recruiting

  • University of Minnesota

    Minneapolis, Minnesota · Not yet recruiting

  • Mayo Clinic - Rochester

    Rochester, Minnesota · Not yet recruiting

  • Saint Luke's Mid America Heart Institute

    Kansas City, Missouri · Not yet recruiting

  • Washington University in St. Louis

    St Louis, Missouri · Recruiting

  • University of Nebraska Medical Center

    Omaha, Nebraska · Not yet recruiting

  • NYU Langone Health

    New York, New York · Not yet recruiting

  • Columbia University Medical Center/ New York Presbyterian Hospital

    New York, New York · Not yet recruiting

  • Duke University Medical Center

    Durham, North Carolina · Not yet recruiting

  • The Lindner Center for Research and Education at The Christ Hospital

    Cincinnati, Ohio · Not yet recruiting

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio · Recruiting

  • Oregon Health & Science University (OHSU)

    Portland, Oregon · Not yet recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Not yet recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Not yet recruiting

  • Baylor College of Medicine

    Houston, Texas · Not yet recruiting

  • Houston Methodist Hospital

    Houston, Texas · Not yet recruiting

  • AZORG - Campus Moorselbaan

    Aalst, Belgium · Not yet recruiting

  • Universite Libre de Bruxelles (ULB) - Hopital Erasme

    Brussels, Belgium · Not yet recruiting

  • Universitair Ziekenhuis Antwerpen (UZA)

    Edegem, Belgium · Not yet recruiting

  • Jessa Ziekenhuis

    Hasselt, Belgium · Not yet recruiting

  • UZ Leuven

    Leuven, Belgium · Not yet recruiting

  • Aarhus University Hospital

    Aarhus, Denmark · Recruiting

  • Rigshospitalet

    Copenhagen, Denmark · Not yet recruiting

  • Odense University Hospital - Odense

    Odense, Denmark · Not yet recruiting

  • CHRU de Tours - Hopital Trousseau

    Chambray-lès-Tours, France · Not yet recruiting

  • CHU de Lille - Institut Coeur Poumon

    Lille, France · Not yet recruiting

  • AP-HP Hopital Pitie-Salpetriere

    Paris, France · Not yet recruiting

  • AP-HP Hopital Europeen Georges Pompidou

    Paris, France · Not yet recruiting

Showing 40 of 78 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.